New Jersey patients deserve access to the best, affordable drugs our high-quality health care system has to offer. PBM reform is essential.

The FTC filed a lawsuit in September, accusing the three major PBMs of anticompetitive rebating practices related to insulin.

Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...

At Camarillo State Hospital, he worked off and on at the “insulin shock ward” from 1939 to 1941. It was a 20-bed dorm for the treatment of schizophrenia in the desperate era before ...

Insulin types vary on the basis of action onset, duration of action, and time to peak activity, as well as optimal administration timing relative to mealtime. The discovery and evolution of insulin ...

Lilly has been under pressure in the US over its pricing for insulin products, and earlier this year launched a generic of its own Humalog brand of fast-acting insulin in an attempt to fend off ...

“The product has a patented spring-loaded system that drives insulin through a small opening in a nozzle, virtually pain free.” The device uses high pressure dispersion through the skin.

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...